Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1854 |  CLDX Celldex Therapeutics, Inc. - Common Stock | 29.30 USD | -3.71% | -9.18% | -24.78% | +7.56% | 2.30 B USD | ||
| 1863 |  SLS SELLAS Life Sciences Group, Inc. - Common Stock | 11.26 USD | -0.44% | -2.09% | -17.87% | +477.44% | 2.27 B USD | ||
| 1889 |  IMNM Immunome, Inc. - Common Stock | 19.31 USD | +1.10% | -9.47% | -27.21% | +37.93% | 2.19 B USD | ||
| 1894 |  AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.22 USD | +1.31% | +1.00% | +1.57% | +35.96% | 2.16 B USD | ||
| 1899 |  VERA Vera Therapeutics, Inc. - Class A Common Stock | 29.73 USD | -1.72% | -4.59% | -14.67% | -0.03% | 2.14 B USD | ||
| 1910 |  BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 8.29 USD | -1.31% | +2.09% | -8.50% | +14.50% | 2.12 B USD | ||
| 1911 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.95 USD | -7.49% | -5.50% | +15.84% | -35.56% | 2.11 B USD | ||
| 1925 |  VRDN Viridian Therapeutics, Inc. - Common Stock | 18.34 USD | +0.33% | -4.28% | -20.64% | -18.31% | 2.08 B USD | ||
| 1931 |  VCEL Vericel Corporation - Common Stock | 40.05 USD | -1.69% | +0.10% | +3.43% | +10.18% | 2.05 B USD | ||
| 1936 |  PHVS Pharvaris N.V. - Ordinary Shares | 31.12 USD | -1.77% | -0.29% | -17.89% | +31.75% | 2.03 B USD | ||
| 1952 |  MLYS Mineralys Therapeutics, Inc. - Common Stock | 22.38 USD | +1.31% | -6.79% | -27.50% | -44.56% | 1.98 B USD | ||
| 1968 |  FTRE Fortrea Holdings Inc. - Common Stock | 20.37 USD | -0.92% | +3.19% | +20.82% | +99.71% | 1.94 B USD | ||
| 1973 |  SRPT Sarepta Therapeutics, Inc. - Common Stock | 18.21 USD | +4.06% | +2.59% | -11.73% | -22.28% | 1.92 B USD | ||
| 1982 |  AGIO Agios Pharmaceuticals, Inc. - Common Stock | 31.92 USD | +0.41% | -2.74% | -3.68% | -26.43% | 1.91 B USD | ||
| 1990 |  VIR Vir Biotechnology, Inc. - Common Stock | 11.12 USD | -3.47% | -3.72% | +0.72% | +85.95% | 1.88 B USD | ||
| 1992 |  MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 7.21 USD | -2.96% | -5.38% | +1.84% | +114.58% | 1.87 B USD | ||
| 1996 |  XERS Xeris Biopharma Holdings, Inc. - Common Stock | 10.19 USD | +0.79% | +9.10% | +19.32% | +24.42% | 1.86 B USD | ||
| 2001 |  GPCR Structure Therapeutics Inc - American Depositary Shares | 25.67 USD | -3.79% | -9.29% | -37.74% | -4.00% | 1.83 B USD | ||
| 2005 |  TRVI Trevi Therapeutics, Inc. - Common Stock | 12.83 USD | -2.36% | -11.46% | -23.77% | +30.52% | 1.83 B USD | ||
| 2008 |  XNCR Xencor, Inc. - Common Stock | 24.50 USD | +0.99% | -3.39% | -2.47% | +96.95% | 1.82 B USD |
Notícias Biotechnology Stocks
Raymond James inicia cobertura da Kymera Therapeutics com recomendação acima da média
Raymond James inicia cobertura da Nektar com classificação de desempenho de mercado
Ação da Palisade Bio inicia cobertura com Outperform na Raymond James
Raymond James mantém recomendação para ações da Liquidia em meio a processos judiciais
Ginkgo Bioworks vai apoiar o programa NSF X-Labs com acesso a laboratório
AbCellera apresentará dados de fase 1/2 sobre candidato a medicamento para menopausa
Quantum-Si detecta 19 aminoácidos no programa de desenvolvimento Proteus
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |